Home › Texas Medicaid holds off on proposed limits for Gilead hepatitis drug
 

Keywords :   


Texas Medicaid holds off on proposed limits for Gilead hepatitis drug

2014-04-11 23:59:42| Biotech - Topix.net

Texas is reconsidering whether to impose strict limits on Gilead Sciences' $84,000 hepatitis C treatment for patients on the state's Medicaid health plan for the poor, at the urging of outside advisers, a state official said on Friday.

Tags: texas drug proposed limits

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06Rockline Industries Wins WOW Innovation Award
26.06IMS Technologies Expands Calcinate Production Site
26.06Horizon expert 'gave evidence based on informal chats'
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
26.06Beckers Commits to Widespread Science Based Targets
26.06PPG to Announce Second-quarter 2024 Results July 18
26.06Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints
26.06Michigan Sets Record Recycling Rate in 2023, Recycles Nearly 70,000 Tons of Materials
More »